Company news

Corvus Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19

February 3, 2021

Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition

December 5, 2020

Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition

November 29, 2020

Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting

November 10, 2020

Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 8, 2020

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results

October 28, 2020

Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China

October 4, 2020

Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors

September 10, 2020

Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19

September 9, 2020

Corvus Announces Participation in Upcoming Investor Conferences

September 7, 2020

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

July 29, 2020

Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020

July 22, 2020

Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19

July 6, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant

May 28, 2020

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results

April 29, 2020

Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2020 Financial Results on April 30, 2020

April 21, 2020

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

March 4, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1b/2 Clinical Trial of Ciforadenant at the 2020 American Society of Clinical Oncology’s Genitourinary Cancers Symposium

February 12, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum

January 31, 2020

Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting

December 6, 2019

Corvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 7, 2019

Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 8, 2019

November 3, 2019

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results

October 28, 2019

← Newer news releases

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 13 decks. Every deck is listed under its year.